Usa Health Store Home Disclaimer | News | Forum | Library | Writer | About | Medicine | Pharmacy
Health Resources
         Drug Information, and Health Articles
Find A Drug:
Health Resources 
 
 Addiction
 
 Aging
 
 Allergy
 
 Anti-Parasitic
 
 Anti-Viral
 
 Antibiotics
 
 Anxiety
 
 Asthma
 
 Blood Pressure
 
 Bone Health
 
 Cancer
 
 Cholesterol
 
 Depression
 
 Diabetes
 
 Gout
 
 Hearing Loss
 
 Heart Cardiovascular
 
 Hemorrhoids
 
 Herb
 
 Herpes
 
 HIV AIDS
 
 Kidney Stones
 
 Lupus
 
 Man Health
 
 Muscle Relaxers
 
 Nausea
 
 Osteoporosis
 
 Pain Relief
 
 Psoriasis
 
 Sexual Health
 
 Skin Care
 
 Sleep Disorders
 
 Stomach
 
 Stop Smoking
 
 Vision Care
 
 Weight Loss
 
 Woman Health
 
 General Health
 
 Drug Manufacturers
 
 Mental Health
 
 Acne
 
 Anti-acidity
 
 Dental
 
 Body Building
Search

Sleep Disorders Last Updated: Aug 6th, 2008 - 09:50:39


NINDS Hypersomnia Information Page
nih.gov, Jul 27, 2006, 09:56

Email this article
 Printer friendly page

Table of Contents (click to jump to sections)
What is Hypersomnia?
Is there any treatment?
What is the prognosis?
What research is being done?

Organizations
Related NINDS Publications and Information
Additional resources from MEDLINEplus

What is Hypersomnia?
Hypersomnia is characterized by recurrent episodes of excessive daytime sleepiness or prolonged nighttime sleep. Different from feeling tired due to lack of or interrupted sleep at night, persons with hypersomnia are compelled to nap repeatedly during the day, often at inappropriate times such as at work, during a meal, or in conversation. These daytime naps usually provide no relief from symptoms. Patients often have difficulty waking from a long sleep, and may feel disoriented. Other symptoms may include anxiety, increased irritation, decreased energy, restlessness, slow thinking, slow speech, loss of appetite, hallucinations, and memory difficulty. Some patients lose the ability to function in family, social, occupational, or other settings. Hypersomnia may be caused by another sleep disorder (such as narcolepsy or sleep apnea), dysfunction of the autonomic nervous system, or drug or alcohol abuse. In some cases it results from a physical problem, such as a tumor, head trauma, or injury to the central nervous system. Certain medications, or medicine withdrawal, may also cause hypersomnia. Medical conditions including multiple sclerosis, depression, encephalitis, epilepsy, or obesity may contribute to the disorder. Some people appear to have a genetic predisposition to hypersomnia; in others, there is no known cause. Hypersomnia typically affects adolescents and young adults.

Is there any treatment?

Treatment is symptomatic in nature. Stimulants, such as amphetamine, methylphenidate, and modafinil, may be prescribed. Other drugs used to treat hypersomnia include clonidine, levodopa, bromocriptine, antidepressants, and monoamine oxidase inhibitors. Changes in behavior (for example avoiding night work and social activities that delay bed time) and diet may offer some relief. Patients should avoid alcohol and caffeine.

What is the prognosis?

The prognosis for persons with hypersomnia depends on the cause of the disorder. While the disorder itself is not life threatening, it can have serious consequences, such as automobile accidents caused by falling asleep while driving. The attacks usually continue indefinitely.

What research is being done?

The NINDS supports and conducts research on sleep disorders such as hypersomnia. The goal of this research is to increase scientific understanding of the condition, find improved methods of diagnosing and treating it, and discover ways to prevent it.

Select this link to view a list of studies currently seeking patients.

Organizations

National Sleep Foundation
1522 K Street NW
Suite 500
Washington, DC   20005
nsf@sleepfoundation.org
http://www.sleepfoundation.org
Tel: 202-347-3471
Fax: 202-347-3472

National Heart, Lung, and Blood Institute Health Information Center
P.O. Box 30105
Bethesda, MD   20824-0105
NHLBIinfo@nhlbi.nih.gov
http://www.nhlbi.nih.gov
Tel: 301-592-8573/240-629-3255 (TTY) Recorded Info: 800-575-WELL (-9355)

Related NINDS Publications and Information


Prepared by:
Office of Communications and Public Liaison
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, MD 20892



NINDS health-related material is provided for information purposes only and does not necessarily represent endorsement by or an official position of the National Institute of Neurological Disorders and Stroke or any other Federal agency. Advice on the treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient's medical history.

All NINDS-prepared information is in the public domain and may be freely copied. Credit to the NINDS or the NIH is appreciated.

Return to top

Last updated June 13, 2006




Top of Page



This site is provided for educational and informational purposes only and is not intended as a substitute
for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
2005 ©    Drug Information, Health Articles, Health news, Medicine       Butalbital | Fioricet SOma | Butalbital